Impact of routine sputum cytology in a population at high risk for bronchial carcinoma

International Journal of Tuberculosis and Lung Disease

Volumn 18, Issue 5, 2014, Pages

  Van Rensburg, A ^a   Neethling, G S ^a   Schubert, P T ^a   Koegelenberg, C F N ^a   Wright, C A ^a   Bolliger, C T ^a   Bernasconi, M ^a   Diacon, Andreas H ^a,b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Cytodiagnosis; Lung cancer; Screening

Indexed keywords

ADULT; AGED; ARTICLE; BRONCHOSCOPY; BRONCHUS OBSTRUCTION; BRONCHUS TUMOR; CANCER CELL; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; COST CONTROL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INOPERABLE CANCER; LUNG CARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; RISK REDUCTION; SPUTUM CYTODIAGNOSIS; CARCINOMA, BRONCHOGENIC; CHI SQUARE DISTRIBUTION; CYTODIAGNOSIS; CYTOLOGY; EPIDEMIOLOGY; EVALUATION STUDY; LUNG NEOPLASMS; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; RADIOGRAPHY; RISK; RISK FACTOR; SOUTH AFRICA; SPUTUM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRONCHOSCOPY; CARCINOMA, BRONCHOGENIC; CHI-SQUARE DISTRIBUTION; CYTODIAGNOSIS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SOUTH AFRICA; SPUTUM;

EID: 84899504136     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.13.0806     Document Type: Article

References (17)

1. The Cancer Association of South Africa. National Cancer Registry. Johannesburg, South Africa: CANSA, 2014. http://www.cansa.org.za. Accessed February 2014.
2. Koegelenberg C F, Aubeelack K, Nanguzgambo A B, et al. Adenocarcinoma the most common cell type in patients presenting with primary lung cancer in the Western Cape. S Afr Med J 2011; 101: 321.
3. Diacon A H, Schuurmans MM, Theron J, et al. Utility of rapid on-site evaluation of transbronchial needle aspirates. Respiration 2005; 72: 182-188. (Pubitemid 40591532)
4. Brundyn K, Koegelenberg C F, Diacon A H, et al. Transbronchial fine-needle aspiration biopsy and rapid on-site evaluation in the setting of superior vena cava syndrome. Diagn Cytopathol 2013; 41: 324-329.
5. Louw M, Brundyn K, Schubert P T, Wright C A, Bolliger C T, Diacon A H. Comparison of the quality of smears in transbronchial fine-needle aspirates using two staining methods for rapid on-site evaluation. Diagn Cytopathol 2012; 40: 777-781.
6. Koegelenberg C F, Bolliger C T, Theron J, et al. Direct comparison of the diagnostic yield of ultrasound-assisted Abrams and Tru-Cut needle biopsies for pleural tuberculosis. Thorax 2010; 65: 857-862.
7. DeRay R M. Art & science of cytopathology. Volume 2. Chapter 21: Lung. Chicago, IL, USA: ASCP Press, 1996.
8. Roby T J, Swan G E, Sorensen K W, Hubbard G A, Schumann G B. Discriminant analysis of lower respiratory tract components associated with cigarette smoking, based on quantitative sputum cytology. Acta Cytologica 1990; 34: 147-154. (Pubitemid 20126111)
9. Gupta K B, Garg S. Sputum induction - a useful tool in diagnosis of respiratory diseases. Lung India 2006; 23: 82-86.
10. Raab S S, Hornberger J, Raffin T. The importance of sputum cytology in the diagnosis of lung cancer. Chest 1997; 112: 937-945. (Pubitemid 27446312)
11. Böcking A, Biesterfeld S, Chatelain R, Gien-Gerlach G, Esser E. Diagnosis of bronchial carcinoma on sections of paraffin-embedded sputum: sensitivity and specificity of an alternative to routine cytology. Acta Cytologica 1992; 36: 37-47.
12. Frable W J. A tribute to Stanley F. Patten. Cancer Cytopathol 1997; 81: 6.
13. th ed. New York, NY, USA: Little Brown and Company, 1994: pp 253-255.
14. Schreiber G, McCrory D C. Performance characteristics of different modalities for diagnosis of suspected lung cancer. Chest 2003; 123: 115-28. http://seer.cancer.gov/csr/1975-2004/results-merged/sect-15-lung-bronchus.pdf Accessed February 2014.
15. Sandler A B, Laskin J J. State of the art in therapy for non-small cell lung cancer. Cancer Invest 2005; 23: 427-442. (Pubitemid 41324361)
16. Subramanian J, Velcheti V, Gao F, Govindan R. Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC). J Thorac Oncol 2007; 2: 827-830. (Pubitemid 47361024)
17. Nagy-Mignotte H, Guillem P, Vesin A, et al. Primary lung adenocarcinoma: characteristics by smoking habit and sex. Eur Respir J 2011; 38: 1412-1419.